07:00 Tue 20 Jul 2021
Induction Healthcare - Major contract renewed with increased scope
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 ("MAR") AND THE RETAINED
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Major contract renewed with increased scope
Contract covering NHS Wales healthcare system renewed for 2022 with additional scope to include front line support services
Induction (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, announces that NHS Wales has renewed its existing contract with Attend Anywhere with an update and expansion of its current scope. This is the first major contract win for Induction since its acquisition of Attend Anywhere in June - the transaction having enhanced Induction's suite of technology products that provide flexible care options for patients and healthcare professionals.
The contract is worth
The COVID-19 pandemic, with the need to radically reduce footfall in hospitals, was a 'super-catalyst' to an already-underway shift toward virtual care, and digital platforms have all grown by a large margin. Providers and patients, who both expect greater flexibility in all aspects of their life, are demanding greater flexibility in the way they deliver and receive care.
Induction Joint CEO
-ENDS-
ENQUIRIES
Induction Dr |
Via Walbrook PR Ltd: induction@walbrookpr.com |
|
|
|
|
Singer Capital Markets (Nominated Adviser and Broker) |
+44 (0) 20 7496 3000 |
|
|
|
|
Walbrook PR Ltd |
+44 (0)20 7933 8780 |
|
|
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) is a leading virtual care platform driving digital transformation of healthcare systems worldwide. Induction solutions enhance the investments hospitals have made and lay the foundation for their future. Our products can enable information sharing between busy doctors, alleviate operational burdens on hospitals or put patients in better control of their care, all while ensuring the highest standards of clinical safety and information security. We unchain staff and patients from the limitations of paper-based and desktop systems, creating substantial time and cost efficiencies.
More than 225,000 hospital doctors across multiple territories, including the
Induction Switch is the number one healthcare collaboration app in the
Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.
Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals.
Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.
Induction Attend Anywhere - www.attendanywhere.com
Attend Anywhere the
Our vision is for video consultations to improve lives and help address social, access, equity and sustainability challenges by allowing healthcare providers to determine how and when they see a patient based on each individual case; in-person, via video or on the telephone. With the addition of Attend Anywhere, our promise of flexible care is truly in motion.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE